Eli Lilly (NYSE: LLY)
Eli Lilly Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Eli Lilly Company Info
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
News & Analysis
The Largest Companies by Market Cap in January 2025
Apple, Nvidia, and Microsoft are the biggest companies by market cap.
Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?
Billionaire Philippe Laffont Is Selling Artificial Intelligence Champion Nvidia and Piling Into These Two Industry Leaders
Is Eli Lilly Stock a Buy?
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades
Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear.
Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for investors.
Is Eli Lilly an Undervalued Growth Stock to Buy Now?
1 Spectacular Growth Stock That Could Join Nvidia, Tesla, Apple, and Others in the $1 Trillion Club
Valuation
Podcast Episodes
Investors Like Certainty. Trump's Win Gave Them Some.
We're also talking about Super Micro, Nvidia, and weight loss.
3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year
These stocks skyrocketed following exciting announcements.
Earnings Transcripts
Eli Lilly (LLY) Q3 2024 Earnings Call Transcript
LLY earnings call for the period ending September 30, 2024.
Eli Lilly (LLY) Q2 2024 Earnings Call Transcript
LLY earnings call for the period ending June 30, 2024.
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript
LLY earnings call for the period ending March 31, 2024.
Eli Lilly (LLY) Q4 2023 Earnings Call Transcript
LLY earnings call for the period ending December 31, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.